Barclays’s FT Vest US Equity Enhance & Moderate Buffer ETF November XNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$164K Buy
4,384
+735
+20% +$27.9K ﹤0.01% 3809
2025
Q4
$138K Sell
3,649
-1,768
-33% -$65.8K ﹤0.01% 4480
2025
Q3
$198K Sell
5,417
-25
-0.5% -$903 ﹤0.01% 4320
2025
Q2
$193K Buy
5,442
+4,621
+563% +$157K ﹤0.01% 4304
2025
Q1
$27.7K Buy
821
+95
+13% +$3.25K ﹤0.01% 4740
2024
Q4
$24.7K Buy
726
+667
+1,131% +$22.7K ﹤0.01% 4890
2024
Q3
$1.98K Buy
+59
New +$1.97K ﹤0.01% 5086

Other funds holding XNOV

Barclays's XNOV Position: Q1 2026 in Review

Barclays increased its FT Vest US Equity Enhance & Moderate Buffer ETF November (XNOV) stake by 20% in Q1 2026, buying an estimated $27.9K and bringing the position to 4,384 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #3809.

Barclays first reported a position in XNOV in Q3 2024 and has held it in 7 quarters since. The position peaked at $198K in Q3 2025. 27 funds tracked by Wall St. Rank hold XNOV as of Q1 2026.

  • Barclays held 4,384 shares of FT Vest US Equity Enhance & Moderate Buffer ETF November worth $164K as of Q1 2026.
  • Barclays bought 735 FT Vest US Equity Enhance & Moderate Buffer ETF November shares in Q1 2026, an estimated $27.9K.
  • FT Vest US Equity Enhance & Moderate Buffer ETF November made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3809 holding.
  • Barclays first reported a position in FT Vest US Equity Enhance & Moderate Buffer ETF November in Q3 2024 and has held it in 7 quarters since.
  • Barclays's FT Vest US Equity Enhance & Moderate Buffer ETF November position peaked at $198K in Q3 2025.
  • 27 funds tracked by Wall St. Rank held FT Vest US Equity Enhance & Moderate Buffer ETF November as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.